<DOC>
	<DOCNO>NCT00646360</DOCNO>
	<brief_summary>Our research significance polyunsaturated fatty acid ( PUFAs ) human development . Specifically , assess effect docosahexanoic acid ( DHA ) supplementation pregnancy infant growth development randomize control intervention trial Cuernavaca , Mexico . This collaborative effort Rollins School Public Health , Emory University , Instituto Nacional de Salud Publica ( INSP ) Instituto Mexicano del Seguro Social ( IMSS ) , Cuernavaca , Mexico . Pregnant woman attend IMSS General Hospital I recruit 18-22 wks gestation assign randomly receive either DHA ( 400 mg ) placebo daily delivery . The main study outcome include ) birth outcome : birth size , gestational age , cord blood level DHA neurodevelopment b ) maternal blood breast milk DHA level 1 3 mo post-partum ) c ) postnatal growth development first 5 year age ) infant DHA status 3 , 12 18 mo . All data collection carry study headquarters ( IMSS ) except home environment assess home visit . Physical growth ( length , weight , head circumference ) infant child development ( visual auditory evoke potential , visual attention , Bayley scale infant development , McCarthy child development score , Hearts Flowers stroop test , computerize child development test ) measure birth , 1 , 3 , 6 , 9 , 12 , 18 , 24 , 36 mo 4 5 year age train worker . Data also obtain socioeconomic status , obstetric history , maternal diet , anthropometry intelligence , quality home environment infant feeding practice . Data analysis include group comparison ( intent-to-treat ) ensure effectiveness randomization , structural equation model examine various pathway DHA supplementation pregnancy affect child growth development . The finding project contribute significantly understanding functional consequence DHA supplementation pregnancy .</brief_summary>
	<brief_title>Effects Prenatal DHA Supplements Infant Development</brief_title>
	<detailed_description />
	<criteria>1822 week pregnant ( base last menstrual period ) 18 35 year old Resident Cuernavaca intend deliver IMSS General Hospital I remain area 2 year follow recruitment Intends predominantly breastfeed infant 3 month age Agrees participate informed consent Exclusion criterion High risk pregnancy : If document clinical record recruitment include history prevalence abruptio placenta , serious bleed episode current pregnancy , gestational diabetes , pregnancy induce hypertension , maternal toxoplasmosis infection pregnancy , coagulation disorder , thrombocytopenia chronic vascular , renal systemic disease drug use . Lipid metabolism ( hyperlipidemia ) and/or absorption disorder Regular intake fish oil DHA supplement pregnancy Chronic use medication illness like epilepsy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>birth size , gestational age , development , child growth ,</keyword>
	<keyword>prenatal nutrition , DHA</keyword>
</DOC>